| Daniel Patrick Dwyer, MD | |
|
9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 | |
| (414) 955-6450 | |
| (414) 955-0082 |
| Full Name | Daniel Patrick Dwyer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356802847 | NPI | - | NPPES |
| 1356802847 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 75829-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Ascension All Saints Hospital | Racine, WI | Hospital |
| Ascension St Francis Hospital | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medicine Specialists Sc | 8729975461 | 195 |
News Archive
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.
Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.
The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.
Advances in surgical options for end-stage ankle arthritis have prompted the American College of Foot and Ankle Surgeons to issue a position statement on the use of total ankle replacement surgery as an option for some patients with painful arthritis.
› Verified 1 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.
Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.
The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.
Advances in surgical options for end-stage ankle arthritis have prompted the American College of Foot and Ankle Surgeons to issue a position statement on the use of total ankle replacement surgery as an option for some patients with painful arthritis.
› Verified 1 days ago
| Entity Name | Emergency Medicine Specialists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568413524 PECOS PAC ID: 8729975461 Enrollment ID: O20040228000032 |
News Archive
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.
Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.
The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.
Advances in surgical options for end-stage ankle arthritis have prompted the American College of Foot and Ankle Surgeons to issue a position statement on the use of total ankle replacement surgery as an option for some patients with painful arthritis.
› Verified 1 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.
Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.
The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.
Advances in surgical options for end-stage ankle arthritis have prompted the American College of Foot and Ankle Surgeons to issue a position statement on the use of total ankle replacement surgery as an option for some patients with painful arthritis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Patrick Dwyer, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 955-6450 | Daniel Patrick Dwyer, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 955-6450 |
News Archive
Pfizer Inc. announced today that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy (pDPN) did not meet its primary efficacy endpoint, change in endpoint mean pain score relative to baseline.
Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.
Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.
The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.
Advances in surgical options for end-stage ankle arthritis have prompted the American College of Foot and Ankle Surgeons to issue a position statement on the use of total ankle replacement surgery as an option for some patients with painful arthritis.
› Verified 1 days ago
Dr. Colleen Ann Crowe, M.D., M.P.H. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6469 | |
Natalia Rumas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2323 N Lake Dr, Milwaukee, WI 53211 Phone: 414-290-6720 Fax: 414-290-6755 | |
Adam C Ankrum, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 E Wisconsin Ave, Suite 2000, Milwaukee, WI 53202 Phone: 414-290-6720 Fax: 414-290-6755 | |
Andrea Michelle Kraus, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3237 S 16th St Ste 100, Milwaukee, WI 53215 Phone: 414-647-5203 Fax: 414-858-2236 | |
Lisa Hubbard, CFNP Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5000 W Chambers St, Milwaukee, WI 53210 Phone: 414-447-2000 Fax: 414-874-4393 | |
Mr. Brad A. Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mckenna Jean Knych, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6450 Fax: 414-805-6464 |